InvestorsHub Logo
Followers 66
Posts 7463
Boards Moderated 0
Alias Born 03/06/2016

Re: McMagyar post# 93312

Sunday, 02/26/2017 3:01:29 PM

Sunday, February 26, 2017 3:01:29 PM

Post# of 462017
McMagyar -

You stated: "What everyone is missing including you is that the Prescription revenue side of Anavex is minuscule compared to its OTC value with continued SAFETY and positive side effect Characterisitcs.

Sleep medication is a greater market..
Depression/ mood is a greater market.
Energy..
Prevention.. "

I understand your point, however, I just don't think the sleep medication / depression mood market will open up before Rhetts or AD.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News